Fully automated radiosynthesis of [

Automation Dopamine transporter PET Parkinson’s disease Radiosynthesis [18F]LBT999

Journal

EJNMMI radiopharmacy and chemistry
ISSN: 2365-421X
Titre abrégé: EJNMMI Radiopharm Chem
Pays: England
ID NLM: 101714628

Informations de publication

Date de publication:
16 Nov 2020
Historique:
received: 16 06 2020
accepted: 19 10 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 17 11 2020
Statut: epublish

Résumé

Fluorine labelled 8-((E)-4-fluoro-but-2-enyl)-3β-p-tolyl-8-aza-bicyclo[3.2.1]octane-2β-carboxylic acid methyl ester ([ Automation of [ Both modules allow efficient and reproducible radiosynthesis of [

Sections du résumé

BACKGROUND BACKGROUND
Fluorine labelled 8-((E)-4-fluoro-but-2-enyl)-3β-p-tolyl-8-aza-bicyclo[3.2.1]octane-2β-carboxylic acid methyl ester ([
RESULTS RESULTS
Automation of [
CONCLUSION CONCLUSIONS
Both modules allow efficient and reproducible radiosynthesis of [

Identifiants

pubmed: 33196944
doi: 10.1186/s41181-020-00105-w
pii: 10.1186/s41181-020-00105-w
pmc: PMC7669936
doi:

Types de publication

Journal Article

Langues

eng

Pagination

26

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-11-LABX-0018-01

Références

J Nucl Med. 2010 Sep;51(9):1331-4
pubmed: 20720060
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1375-1382
pubmed: 28314910
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):443-50
pubmed: 19838702
Q J Nucl Med Mol Imaging. 2019 Sep 05;:
pubmed: 31496203
Nucl Med Biol. 2014 Jan;41(1):106-13
pubmed: 24210285
Synapse. 1994 Feb;16(2):93-103
pubmed: 8197578
Nucl Med Biol. 2007 May;34(4):465-70
pubmed: 17499737
Neuropsychopharmacology. 2016 Aug;41(9):2294-302
pubmed: 26892922
Parkinsonism Relat Disord. 2017 Sep;42:66-72
pubmed: 28662820
J Neurol Sci. 2015 Dec 15;359(1-2):161-71
pubmed: 26671107
Q J Nucl Med Mol Imaging. 2012 Feb;56(1):68-82
pubmed: 22460161
J Nucl Med. 2011 Aug;52(8):1313-21
pubmed: 21764797
J Psychiatr Res. 2009 Oct;43(15):1219-23
pubmed: 19457493
Clin Nucl Med. 2011 Aug;36(8):656-60
pubmed: 21716015
Bioorg Med Chem. 2009 Nov 15;17(22):7630-4
pubmed: 19846314
Neurol Sci. 2001 Feb;22(1):47-8
pubmed: 11487195
Bioorg Med Chem. 2006 Feb 15;14(4):1115-25
pubmed: 16219467
Synapse. 1993 Oct;15(2):130-42
pubmed: 8259524
Ageing Res Rev. 2016 Sep;30:114-21
pubmed: 26802555
J Neuroimaging. 2013 Apr;23(2):192-6
pubmed: 22211920
Synapse. 2009 Oct;63(10):871-80
pubmed: 19562698
Synapse. 2007 Jan;61(1):17-23
pubmed: 17068778
Synapse. 1998 Mar;28(3):244-50
pubmed: 9488509
J Nucl Med. 2003 Jun;44(6):855-61
pubmed: 12791810
J Nucl Med. 1998 Sep;39(9):1521-30
pubmed: 9744335
J Nucl Med. 2012 Jul;53(7):1065-73
pubmed: 22689927
J Pharmacol Exp Ther. 2006 Apr;317(1):147-52
pubmed: 16339913
Front Neurol. 2020 Aug 21;11:754
pubmed: 32973645

Auteurs

Christine Vala (C)

Zionexa, 75017, Paris, France.
Cyclopharma, 63360, Saint-Beauzire, France.
CERRP, 37100, Tours, France.

Céline Mothes (C)

Zionexa, 75017, Paris, France.
Cyclopharma, 63360, Saint-Beauzire, France.
CERRP, 37100, Tours, France.

Gabrielle Chicheri (G)

CERRP, 37100, Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, 37000, Tours, France.

Pauline Magadur (P)

Cyclopharma, 63360, Saint-Beauzire, France.
CERRP, 37100, Tours, France.

Gilles Viot (G)

Cyclopharma, 63360, Saint-Beauzire, France.

Jean-Bernard Deloye (JB)

Zionexa, 75017, Paris, France.
Cyclopharma, 63360, Saint-Beauzire, France.
CERRP, 37100, Tours, France.

Serge Maia (S)

CERRP, 37100, Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, 37000, Tours, France.
INSERM CIC 1415, University Hospital, 37000, Tours, France.
CHRU de Tours, services de Médecine Nucléaire in vitro et in vivo, 37000, Tours, France.

Yann Bouvet (Y)

Zionexa, 75017, Paris, France.
Cyclopharma, 63360, Saint-Beauzire, France.

Anne-Claire Dupont (AC)

CERRP, 37100, Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, 37000, Tours, France.
INSERM CIC 1415, University Hospital, 37000, Tours, France.
CHRU de Tours, services de Médecine Nucléaire in vitro et in vivo, 37000, Tours, France.

Nicolas Arlicot (N)

CERRP, 37100, Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, 37000, Tours, France.
INSERM CIC 1415, University Hospital, 37000, Tours, France.
CHRU de Tours, services de Médecine Nucléaire in vitro et in vivo, 37000, Tours, France.

Denis Guilloteau (D)

CERRP, 37100, Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, 37000, Tours, France.
INSERM CIC 1415, University Hospital, 37000, Tours, France.
CHRU de Tours, services de Médecine Nucléaire in vitro et in vivo, 37000, Tours, France.

Patrick Emond (P)

CERRP, 37100, Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, 37000, Tours, France.
CHRU de Tours, services de Médecine Nucléaire in vitro et in vivo, 37000, Tours, France.

Johnny Vercouillie (J)

CERRP, 37100, Tours, France. vercouillie@univ-tours.fr.
UMR 1253, iBrain, Université de Tours, Inserm, 37000, Tours, France. vercouillie@univ-tours.fr.
INSERM CIC 1415, University Hospital, 37000, Tours, France. vercouillie@univ-tours.fr.

Classifications MeSH